Hong Kong Stock Movement | Alebund Pharmaceuticals-B (09637.HK) Soars Over 17% in Afternoon Session; Clinical Application for AP308, a New Drug for IgA Nephropathy, Approved by U.S. FDA

Zhito Finance APP has learned that Alebund Pharmaceuticals-B (09637.HK) surged over 17% in the afternoon. As of press time, it was up 12.96%, at HK$25.98, with a turnover of HK$36.2796 million.